When Statin Guidelines Collide: 5 Questions on 2 Approaches to Primary CVD Prevention


Guidelines on primary ASCVD prevention from the USPSTF and the AHA/ACC/Multisociety differ on why and when to initiate a statin. Try the 5-question quiz.

Clinical guidelines on the primary prevention of atherosclerotic cardiovascular disease (ASCVD) from the United States Preventative Services Taskforce (USPSTF; 2022)1 and the American Heart Association/American College of Cardiology/Multisociety ( AHA/ACC/MS; 2018),2 are 2 of the leading resources for evidence-based recommendations on how to mitigate risk of a first CVD event. They differ, however, in the risk factors that suggest and level of risk at which a statin should be initiated.

The following 5 questions test what you know about the differences and the benefit-risk balance of statin therapy.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
© 2023 MJH Life Sciences

All rights reserved.